August 5, 2015

August 5, 2015 – Aimmune Therapeutics announced today the pricing of its initial public offering at $16.00 per share. Trading is to begin tomorrow on NASDAQ under the symbol AIMT. Company press release. FLG partner: Victor Colunga.